For PDLIM3, the results of IHC in the stroma are comparable to those of MS, and its abundant responses to CP in IHC in the tumour are different from its signals gained from MS PDLIM3 increases in CP‐s in IHC but no change in MS. The gene discussed is CP; the disease is neoplasm.